Search Result "G2/M phase checkpoints"
Targeting the G2/M Transition for Antitumor Therapy
Journal: Letters in Drug Design & Discovery
Volume: 2 Issue: 4 Year: 2005 Page: 274-281
Author(s): J. Yuan, K. Strebhardt
Topoisomerase II Inhibitors and Poisons, and the Influence of Cell Cycle Checkpoints
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 1 Year: 2017 Page: 1504-1519
Author(s): Nicholas D`Arcy,Brian Gabrielli
CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 8 Year: 2012 Page: 949-958
Author(s): Alberta Bergamo,Riccarda Delfino,Claudia Casarsa,Gianni Sava
Novel Checkpoint 1 Inhibitors
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 1 Year: 2006 Page: 55-68
Author(s): Michelle Prudhomme
Combining DNA Damaging Agents and Checkpoint 1 Inhibitors
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 4 Issue: 5 Year: 2004 Page: 435-438
Author(s): Michelle Prudhomme
Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2013 Page: 1609-1619
Author(s): Iranzu Lamberto, Daniel Plano, Esther Moreno, Maria Font, Juan Antonio Palop, Carmen Sanmartin, Ignacio Encio
Current Inhibitors of Checkpoint Kinase 2
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 4368-4374
Author(s): T. N.T. Nguyen, J. J. Tepe
Modulation of DNA Damage Checkpoint; Patenting and Possible Application for Cancer Medicine
Journal: Recent Patents on DNA & Gene Sequences (DIscontinued)
Volume: 2 Issue: 1 Year: 2008 Page: 34-39
Author(s): Kazuhiro Ishikawa, Hideshi Ishii, Keiichi Ichimura
Cell Cycle Checkpoint Genes and Aneuploidy: A Short Review
Journal: Current Genomics
Volume: 2 Issue: 2 Year: 2001 Page: 171-180
Author(s): William G. Kearns, Johnson M. Liu
Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 3 Year: 2010 Page: 186-191
Author(s): Suzanne Leijen, Jos H. Beijnen, Jan H.M. Schellens